Zobrazeno 1 - 10
of 243
pro vyhledávání: '"vaginal microbicides"'
Publikováno v:
HIV/AIDS: Research and Palliative Care, Vol Volume 13, Pp 399-413 (2021)
Sabdat O Ekama,1,2 Margaret O Ilomuanya,1 Chukwuemeka P Azubuike,1 Tajudeen A Bamidele,2 Muinah A Fowora,2 Oluwagbemiga O Aina,2 Oliver C Ezechi,2 Cecilia I Igwilo1 1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Univ
Externí odkaz:
https://doaj.org/article/ff1d6fe759434abfaea9640684009ac0
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Background: Vaginal drug delivery offers an opportunity for effective microbicide treatments. However, the physiological characteristics of the vagina represent a challenge when preparing microbicide formulations for local delivery that avoid systemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cffc6afdbaeb3115547aff0847738acc
https://doi.org/10.2174/0929867328666201209095753
https://doi.org/10.2174/0929867328666201209095753
Autor:
Oliver Ezechi, O O Aina, Tajudeen A. Bamidele, Muinah A Fowora, C.I. Igwilo, C.P. Azubuike, Margaret O. Ilomuanya, Sabdat O. Ekama
Publikováno v:
HIV/AIDS (Auckland, N.Z.)
Purpose To formulate and evaluate microspheres of the antiretroviral drugs maraviroc and tenofovir intended for a candidate vaginal microbicide and assess its effect on the vaginal lactic acid bacteria microflora. Methods Ionic gelation technique was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6af1816df0e60b3abe4932414b21831e
https://doi.org/10.2147/hiv.s291065
https://doi.org/10.2147/hiv.s291065
Autor:
Araceli Martín-Illana, Fernando Notario-Pérez, Raúl Cazorla-Luna, Roberto Ruiz-Caro, María Dolores Veiga
Publikováno v:
Pharmaceutics, Vol 11, Iss 5, p 232 (2019)
Sub-Saharan African women are still at risk from the human immunodeficiency virus (HIV), and sex with men is the main route of transmission. Vaginal formulations containing antiretroviral drugs are promising tools to give women the power to protect t
Externí odkaz:
https://doaj.org/article/a50e89d85aa5431086128b0616621b97
Publikováno v:
Sexually Transmitted Infections
ObjectivesParticipation in HIV prevention trials could trigger risk compensation among participants. We evaluated potential risk compensation following use of a vaginal ring microbicide by women in a phase III trial in southwestern Uganda.MethodsWe u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ca36be7c2fc6ed16bb83c2419422f63
https://doi.org/10.1136/sextrans-2020-054718
https://doi.org/10.1136/sextrans-2020-054718
Autor:
Ellen H Luecke, Helen Cheng, Kubashni Woeber, Teopista Nakyanzi, Imelda C Mudekunye‐Mahaka, Ariane van derStraten, on behalf of the MTN‐003D Study Team
Publikováno v:
Journal of the International AIDS Society, Vol 19, Iss 1, Pp n/a-n/a (2016)
Introduction The effectiveness of HIV pre‐exposure prophylaxis (PrEP) requires consistent and correct product use, thus a deeper understanding of women's stated product formulation preferences, and the correlates of those preferences, can help guid
Externí odkaz:
https://doaj.org/article/ccac942f6f8545a2a158da7211390e02
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2008 Jul . 105(28), 9835-9840.
Externí odkaz:
https://www.jstor.org/stable/25463059
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Martín-Illana, A., Cazorla-Luna, Raúl, Notario-Pérez, Fernando, Rubio Alonso, Juan, Ruiz-Caro, Roberto, Tamayo Hernando, Aitana, Veiga, María Dolores
Publikováno v:
E-Prints Complutense. Archivo Institucional de la UCM
instname
instname
[EN] The high rate of HIV new infections and AIDS-related deaths each year make prevention tools still necessary today. Different dosage forms – including films – for vaginal administration of antiretroviral drugs have been developed for this pur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f649305f0162b919421d7a0388df381f
https://doi.org/10.1016/j.ijpharm.2022.121554
https://doi.org/10.1016/j.ijpharm.2022.121554
Autor:
Kate M. Guthrie, John E. Hayes, Gregory R. Ziegler, Alyssa J. Bakke, Kimberly Powell, Toral Zaveri
Publikováno v:
BMC Women's Health, Vol 18, Iss 1, Pp 1-17 (2018)
BMC Women's Health
BMC Women's Health
Background Vaginal microbicides are a promising means to prevent the transmission of HIV and other sexually transmitted infections, by empowering women to initiate use prophylactically when they perceive themselves to be at risk. However, in clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5828f6078c5758888efccb4cb3fd0021
http://link.springer.com/article/10.1186/s12905-018-0657-2
http://link.springer.com/article/10.1186/s12905-018-0657-2